Study summary · research use only
[Conjugates of 2',3'-didehydro-3'-deoxythymidine with thymogen. Synthesis and anti-HIV activity]
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This chemistry study describes the synthesis of thymogen and of conjugates linking the nucleoside 2',3'-didehydro-3'-deoxythymidine (d4T) to thymogen through tryptophan or glutamic acid residues. The authors report that the anti-HIV activity of the d4T-thymogen conjugate with the tryptophan linkage was comparable to that of d4T, while its cytotoxicity was described as nil, and that the d4T-tryptophan conjugate also showed anti-HIV activity. No living species or organism was studied; this is a synthetic and in vitro activity report. The abstract provides no further quantitative detail.
Abstract
An effective synthesis of thymogen was developed. Conjugates of 2',3'-didehydro-3'-deoxythymidine (nucleoside d4T) with thymogen were prepared in which the nucleoside hydroxyl group was linked to the thymogen carboxyl group of either tryprophan or glutamic acid residues. It was shown that the anti-HIV activity of the d4T-thymogene conjugate with the tryptophan linkage was comparable to that of d4T, whereas its cytotoxicity was nil. The d4T-tryptophan conjugate also displayed high anti-HIV activity.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.